Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|67|2|612-622

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.67, Iss.2, 2018-02, pp. : 612-622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 85-92

Karger

Access to resources Recommend Favorite

Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 152-157

Karger

Access to resources Recommend Favorite

Complete Response after Short-Term Sorafenib Treatment in a Patient with Lymph Node Metastasis of Hepatocellular Carcinoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-07 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

MicroRNA‐425‐3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 1077-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite

Education and Imaging

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 438-438

John Wiley & Sons Inc

Access to resources Recommend Favorite